Trigonotin C;(+)-Trigonotin C



Compound IDCDAMM00449
Common nameTrigonotin C;(+)-Trigonotin C
IUPAC name8,20-dihydroxy-5-(4-hydroxy-3-methoxyphenyl)-19-(hydroxymethyl)-7,9-dimethoxy-19-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,15,18-trioxatetracyclo[15.2.1.04,13.06,11]icosa-6,8,10,12-tetraene-3,14-dione
Molecular formulaC33H38O18

Experimental data

Retention time15.31
Adduct[M+H]+
Actual mz723.209
Theoretical mz723.213
Error5.64
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.989

Identifiers and class information

Inchi keyVZLIQNLXUYMNAA-UZLOGRJRNA-N
SmilesO=C1OCC2OC(OC3OC(CO)C(O)C(O)C3O)(CO)C(OC(=O)C4C1=CC=5C=C(OC)C(O)=C(OC)C5C4C6=CC=C(O)C(OC)=C6)C2O
SuperclassLignans, neolignans and related compounds
ClassLignan glycosides

Pharmacokinetic properties

Number of descriptor values(#stars)7
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)722.652
Computed dipole moment(dipole)8.537
Total solvent accessible surface area (SASA)821.976
Hydrophobic component of SASA (FOSA)444.807
Hydrophilic component of SASA (FISA)295.192
Pie component of the SASA (PISA)81.977
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1738.65
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)21.15
Free energy of solvation of dipole (dip^2/V)0.0419206
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0727773
Globularity descriptor (glob)0.850707
Predicted polarizability in cubic angstroms (QPpolrz)54.578
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.422
Predicted octanol/gas partition coefficient (QPlogPoct)42.487
Predicted water/gas partition coefficient (QPlogPw)33.503
Predicted octanol/water partition coefficient (QPlogPo/w)-0.78
Predicted aqueous solubility (QPlogS)-2.34
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.833
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.339
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)15.725
Predicted brain/blood partition coefficient (QPlogBB)-3.06
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.56
Predicted skin permeability, log Kp (QPlogKp)-5.231
PM3 calculated ionization potential (IP(ev))8.578
PM3 calculated electron affinity (EA(eV))0.818
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)-0.951
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)4.921
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)256.69
Number of nitrogen and oxygen atoms (#NandO)18
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P11926ODC1Ornithine decarboxylaseT60366SEA
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
Q9P0J0NDUFA13Mitochondrial complex IT82391SEA
Q9Y6M9NDUFB9HUMAN NADH:ubiquinone oxidoreductase subunit B9T01465SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
P03897MT-ND3NADH dehydrogenaseT77195SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T82391DI0069Cardiomyopathy[ICD-11: BC43]Q9P0J0NDUFA13
T77195DI0331Parkinsonism[ICD-11: 8A00]P03897MT-ND3

Copyright © 2025